Publications – Page 2 – KalVista Pharmaceuticals

Showing 11-20 out of 24

Treatment of HAE Attacks with Anticipated Future Oral On-Demand Therapies as Reported by Patients

Valerieva A, Jones D, van Kooten S, Malloy N, Heckmann M, Betschel S
EAACI 2024

Patient-Reported Benefits of Early On-Demand Treatment of HAE Attacks

Longhurst H, Guilarte M, van Kooten S, Malloy N, Heckmann M, Busse P
EAACI 2024

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Savic S, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya P, Yong P
EAACI 2024

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks

Yong P, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya P, Savic S
EAACI 2024

Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

O’Connor M, Busse P, Craig T, Radojicic C, Christiansen S, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V
EAC 2024

Burden of Untreated Hereditary Angioedema Attacks Impact on Social, Mental, and Physical Health

Radojicic C, Busse P, O’Connor M, Ulloa J, Danese S, Desai V, Andriotti T, Audhya P, Christiansen S

Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

Busse P, Craig T, Radojicic C, O’Connor M, Christiansen S, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V

Relationship Between Time to On-demand Treatment and Quality of Life During Hereditary Angioedema Attacks

Christiansen S, Craig T, O’Connor M, Radojicic C, Ulloa J, Danese S, Desai V, Andriotti T, Audhya P, Busse P

The Impact of On-demand Treatment on Quality of Life of People with HAE (#265)

Paula Busse, Bob Geng, Sally van Kooten, Neil Malloy, Markus Heckmann, Julie Ulloa, Douglas H. Jones

Characterizing the Negative Impact of Delayed On-Demand Treatment of HAE Attacks (#284)

Princess Ogbogu, Hilary Longhurst, Sally van Kooten, Neil Malloy, Markus Heckmann, Julie Ulloa, Ricardo Zwiener

About